Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Accounts Payable & Accrued Expense : ¥227 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical Accounts Payable & Accrued Expense?

Sichuan Goldstone Asia Pharmaceutical's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥353 Mil) to Dec. 2023 (¥295 Mil) and declined from Dec. 2023 (¥295 Mil) to Mar. 2024 (¥227 Mil).

Sichuan Goldstone Asia Pharmaceutical's annual accounts payable & accrued expense increased from Dec. 2021 (¥268 Mil) to Dec. 2022 (¥360 Mil) but then declined from Dec. 2022 (¥360 Mil) to Dec. 2023 (¥295 Mil).

Sichuan Goldstone Asia Pharmaceutical Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical Accounts Payable & Accrued Expense Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

241.82

228.86

267.60

360.18

294.71

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															313.37	386.25	353.48	294.71	226.55

Sichuan Goldstone Asia Pharmaceutical Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072

Website

http://www.goldstone-group.com

Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Headlines

No Headlines